T 2168/17 (Combination therapy 2/GENENTECH) of 20.04.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T216817.20210420
- Date of decision
- 20 April 2021
- Case number
- T 2168/17
- Online on
- 15 November 2021
- Petition for review of
- -
- Application number
- 10009416.8
- IPC class
- C07K 16/00A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Combination therapy for B cell disorders
- Applicant name
- Genentech, Inc.
- Opponent name
- GlaxoSmithKline Intellectual Property
Management Limited - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Late-filed request - admitted (yes)
Inventive step - (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.